Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

8,024 public trials 710 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)

NCT02803918

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 840002 Baton Rouge, Louisiana, United States
  • Investigational Site Number 840006 New Orleans, Louisiana, United States
  • Investigational Site Number 840009 Philadelphia, Pennsylvania, United States
  • Investigational Site Number 840007 Lufkin, Texas, United States
View Trial Details
Completed

A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period

NCT03414736

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 8400002 Saint Paul, Minnesota, United States
  • Investigational Site Number 8400003 Knoxville, Tennessee, United States
  • Investigational Site Number 8400001 Austin, Texas, United States
View Trial Details
Completed

Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)

NCT02545842

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 156053 Anshan, China
  • Investigational Site Number 156001 Beijing, China
  • Investigational Site Number 156002 Beijing, China
  • Investigational Site Number 156006 Beijing, China
View all 44 locations
View Trial Details
Completed

Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin

NCT03760991

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational site Argentina Buenos Aires, Argentina
  • investigational site COLOMBIA Colombia
  • investigational site Egypt Egypt
  • investigational site HONG KONG Hong Kong
View all 14 locations
View Trial Details
Completed

Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)

NCT03767543

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 1240004 Barrie, Canada
  • Investigational Site Number 1240006 Brampton, Canada
  • Investigational Site Number 1240002 Brampton, Canada
  • Investigational Site Number 1240005 Burlington, Canada
View all 32 locations
View Trial Details

Related conditions